Beneficial effect of antibodies against β- secretase cleavage site of APP on Alzheimer's-like pathology in triple-transgenic mice.
The toxicity of amyloid β and tau, the two hallmark proteins in Alzheimer's disease (AD), has been extensively studied individually. Recently new data suggest their possible interactions and synergistic effects in the disease. In this study, we investigate the ability of antibodies against the...
Main Authors: | Inna Rabinovich-Nikitin, Idan S Rakover, Maria Becker, Beka Solomon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3468631?pdf=render |
Similar Items
-
Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer’s disease
by: Seong Su Kang, et al.
Published: (2020-08-01) -
Delta-secretase triggers Alzheimer’s disease pathologies in wild-type hAPP/hMAPT double transgenic mice
by: Zhourui Wu, et al.
Published: (2020-12-01) -
γ-Secretase Modulators and APH1 Isoforms Modulate γ-Secretase Cleavage but Not Position of ε-Cleavage of the Amyloid Precursor Protein (APP).
by: Christian B Lessard, et al.
Published: (2015-01-01) -
γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not
by: Christian B. Lessard, et al.
Published: (2020-05-01) -
Inhibition of CXCR4/CXCL12 signaling: a translational perspective for Alzheimer’s disease treatment
by: Yuval Gavriel, et al.
Published: (2022-01-01)